Cargando…

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C

Patient: Female, 43 Final Diagnosis: — Symptoms: Diarrhea • generalized weakness • headache • lightheadedness • nausea • rash • short of breath • vomiting Medication: — Clinical Procedure: — Specialty: Pulmonology OBJECTIVE: Rare diseae BACKGROUND: IFN-alpha-2b in combination with ribavirin is now t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trien, Remi, Cooper, Chad J., Paez, David, Colon, Edgardo, Ajmal, Shajeea, Salameh, Hasan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043539/ https://www.ncbi.nlm.nih.gov/pubmed/24900166 http://dx.doi.org/10.12659/AJCR.890180

Ejemplares similares

Dilated cardiomyopathy secondary to chronic cocaine abuse: a case report
por: Cooper, Chad J, et al.
Publicado: (2013)

Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review
por: Said, Sarmad, et al.
Publicado: (2014)

Bird fanciers’ lung induced by exposure to duck and goose feathers
por: Cooper, Chad J., et al.
Publicado: (2014)

Multisystem Sarcoidosis in a Patient on Interferon-α Therapy for Chronic Hepatitis C
por: Oudghiri, Bouchra, et al.
Publicado: (2012)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
por: Rodríguez-Lojo, R., et al.
Publicado: (2010)

Propionibacterium acnes-associated Sarcoidosis Possibly Initially Triggered by Interferon-alpha Therapy
por: Sawahata, Michiru, et al.
Publicado: (2020)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
por: Scagnolari, Carolina, et al.
Publicado: (2010)

Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C
por: Martins, Elson Vidal, et al.
Publicado: (2009)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
por: Pantazis, Konstantinos D., et al.
Publicado: (2008)

Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
por: Sweiss, Nadera J., et al.
Publicado: (2011)

Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
por: Krupińska, Janina, et al.
Publicado: (2012)

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
por: Shwaylia, Hawraa, et al.
Publicado: (2021)

Pegylated Interferon-Induced Sarcoidosis Presenting With Anterior Uveitis in a Patient with Chronic Hepatitis C - Case Report
por: KAMAL, A.M., et al.
Publicado: (2015)

‘Double-hit’ pegylated interferon-alpha successfully treats Hepatitis B and Hepatitis D co-infection
por: Bhuva, Meha, et al.
Publicado: (2020)

B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
por: Kajiyama, Yusuke, et al.
Publicado: (2012)

Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
por: Kashif, Muhammad, et al.
Publicado: (2015)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C
por: Dhillon, Sonu, et al.
Publicado: (2010)

Hepatic Sarcoidosis
por: Tadros, Micheal, et al.
Publicado: (2013)

Evaluation of immune response profiles of individuals with chronic Hepatitis C treated with interferon alpha and ribavirin, in the foundation of tropical medicine of Amazonas
por: Araújo, Ana Ruth, et al.
Publicado: (2010)

Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors
por: Yan, Zehui, et al.
Publicado: (2012)

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy
por: Carta, Mauro G, et al.
Publicado: (2007)

Nanomedicines in the treatment of chronic hepatitis C – focus on pegylated interferon alpha-2a
por: Thomas, Thea, et al.
Publicado: (2007)

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2010)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
por: Boldanova, Tujana, et al.
Publicado: (2017)

Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin
por: Chudhary, Hafiza Rida Farooq, et al.
Publicado: (2023)

Hepatitis C- and HIV-induced porphyria cutanea tarda
por: Quansah, Raphael, et al.
Publicado: (2014)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
por: Younossi, Zobair M, et al.
Publicado: (2012)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
por: Liu, Yisi, et al.
Publicado: (2023)

Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine
por: Pereira, Eduardo Guimarães, et al.
Publicado: (2016)

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV – focus on pegylated interferon-alpha
por: Zoller, Heinz, et al.
Publicado: (2006)

Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C
por: Sheth, Hiten G, et al.
Publicado: (2010)

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
por: Choi, Jong Wook, et al.
Publicado: (2016)

The Natural History Model of Hepatitis C Virus Infection and the Economic Evaluation of Alpha Interferon Treatment
por: Hayashida, Kenshi, et al.
Publicado: (2007)

Evaluation of health status in patients with hepatitis c treated with and without interferon
por: Ragusa, R., et al.
Publicado: (2018)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Interferon-inducible chemokines reflect severity and progression in sarcoidosis
por: Su, Robert, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qb86t80gno1fkv3ilkp9bi3gkm